Reaction profile
The FDA adverse-event record for labelled drug-disease interaction medication error
25 FDA reports name labelled drug-disease interaction medication error, a lower-volume reaction in the CVM extract (VeDDRA 99841). Plate stamps and neighbourhood peers follow.
- #2072 of 2,481
- by report volume (all reactions)
- 25
- reports citing this reaction
- 32.0%
- death-coded share
- Dog
- most-affected species
Release-over-release change
What changed in the latest FDA data snapshot
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Labelled drug-disease interaction medication error has 25 reports now versus 25 in that prior snapshot: 0 the same number of (0.0%).
- Report change
- +0
- Death-coded reports
- +0
- Death-coded share
- +0.0 pts
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Labelled drug-disease interaction medication error changesFDA AER · VeDDRA plate
Code 99841 VOL-TRACE
VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL
- VOL-TRACE 25 reports
- DEATH-HOT 32.0%
- LOWER-Q #2072/2481
- PHOTO-FINISH Abnormal behaviour NOS
- SPECIES-DOG Dog · 20
- DRUG-LEAD Milbemycin Oxime… · 5
- DESK-WIDE 17 breeds
- BOOK-FULL 8/8 fields
Nearest volume peer: Abnormal behaviour NOS (±0 reports)
Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.
Lower-volume neighbourhood around Labelled drug-disease interaction medication e…
Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.
Labelled drug-disease interaction medication error: high death-coded share in the FDA AER plate
Signature read: 25 reports place Labelled drug-disease interaction medication error in the lower third of FDA AER volume (#2072 of 2,481). Report volume is lower-third scale: 25 named reports in the openFDA extract. Death-coded share is upper-third: 8 of 25 reports (32.0% of named reports). Nearest volume peer: Abnormal behaviour NOS (±0 reports). Lead species Dog (20). Lead co-reported drug Milbemycin Oxime + Spinosad (5).
Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.
Species Most Affected
Breeds Most Affected
Associated Drugs
What to do with this reaction
- Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
- Browse the full reaction directory to compare report counts across reaction types. All reactions
A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →